The Pivotal Immunomodulatory and Anti-Inflammatory Effect of Histone-Lysine N-Methyltransferase in the Glioma Microenvironment: Its Biomarker and Therapy Potentials
Enhancer of zeste homolog 2 (EZH2) is a histone-lysine N-methyltransferase that encrypts a member of the Polycomb group (PcG) family. EZH2 forms a repressive chromatin structure which eventually participates in regulating the development as well as lineage propagation of stem cells and glioma progre...
Saved in:
Main Authors: | Seidu A. Richard, Kuugbee D. Eugene |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2021/4907167 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PRMT7: A Pivotal Arginine Methyltransferase in Stem Cells and Development
by: Bingyuan Wang, et al.
Published: (2021-01-01) -
Targeting the lysine lactylome for the treatment of glioma
by: Di Wang, et al.
Published: (2024-12-01) -
Inhibition of Histone Methyltransferase, Histone Deacetylase, and β-Catenin Synergistically Enhance the Cardiac Potential of Bone Marrow Cells
by: Jinpu Yang, et al.
Published: (2017-01-01) -
The histone methyltransferase DOT1B is dispensable for stage differentiation and macrophage infection of Leishmania mexicana
by: Nicole Eisenhuth, et al.
Published: (2025-01-01) -
Glioma Stem Cells: Signaling, Microenvironment, and Therapy
by: Brandon D. Liebelt, et al.
Published: (2016-01-01)